High, Katherine A. http://orcid.org/0000-0002-0805-6223
Article History
Received: 12 May 2020
Accepted: 15 August 2020
First Online: 16 November 2020
Competing interests
: The author declares the following competing interests: Formerly employed by and held equity in Spark Therapeutics (2014–2020); member of the Board of Directors, CRISPR Therapeutics (2019–present).